New weight loss pill beats oral Ozempic in major trial

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs li This story matters for Health & Wellness readers tracking wellness. Reported by sciencedaily.com. Read the full original at the source link below.